SEP 13, 2020 10:50 AM PDT

Scientists Find Way to Reduce Inflammation from Vaccines

WRITTEN BY: Annie Lennon

Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a key ingredient in modern vaccines that helps create an immuno-response that protects against various diseases. 

While adjuvants are useful for activating inflammatory cytokines that are then able to protect against various diseases, some cause an excessive inflammatory response in the body and are thus difficult to implement in vaccine development. As such, the researchers behind the present study wanted to find a way to limit the possibility of inflammation while still guaranteeing the desired immune response. 

After some searching, they came across a peptide known as SN50, which, as tests demonstrated, had the potential to disrupt pathways in cells that typically lead to excessive inflammation. In particular, this molecule seemed to interrupt a protein called NF-kB, known to produce inflammatory cytokines. Adding the molecule to a range of drugs, they found it was able to reduce inflammation and increase antibodies against various diseases in mouse models. 

In mice with dengue, for example, they found that the molecule helped the body produce more antibodies to neutralize the virus. Meanwhile, in those with HIV, they found it also helped produce more antibodies that targeted hard-to-reach areas of the virus. It was also able to enhance a pre-existing flu vaccine's efficacy. 

The next step for the researchers is to find whether a molecule smaller than a peptide is able to produce the same results. They also want to investigate how such a molecule could aid immunotherapy treatments for cancer and other health conditions. In particular, they say that their research has many implications for how vaccines may be designed in the next 5- 10 years, and could one day aid in the development of vaccines against SARS-CoV-2, especially if it becomes a seasonal threat. 

 

Sources: Neuroscience NewsScience Advances

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 10, 2021
Drug Discovery & Development
Inflammation during pregnancy can affect normal brain development
NOV 10, 2021
Inflammation during pregnancy can affect normal brain development
During pregnancy the growing embryo and fetus undergo remarkable and quick developmental. Around 5 weeks after ...
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
DEC 15, 2021
Drug Discovery & Development
New study launches Viagra into the spotlight as the next drug to treat Alzheimer's disease
DEC 15, 2021
New study launches Viagra into the spotlight as the next drug to treat Alzheimer's disease
A recent study, published in the journal Nature Aging, reaffirmed the role of Sildenafil (brand name Viagra) in tre ...
JAN 01, 2022
Health & Medicine
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
JAN 01, 2022
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine ...
JAN 20, 2022
Clinical & Molecular DX
Nanoparticles Put To the Test: No Glow, No-Go
JAN 20, 2022
Nanoparticles Put To the Test: No Glow, No-Go
  Nanoparticles—tiny spheres carrying a biologically-active cargo—have the potential to transform how w ...
JAN 21, 2022
Cannabis Sciences
CBD inhalant effective in reducing glioblastoma tumors
JAN 21, 2022
CBD inhalant effective in reducing glioblastoma tumors
Researchers at Augusta University found that hat CBD inhalant can alter the lung microenvironment and subsequently inhib ...
Loading Comments...